Cita APA (7a ed.)

N, L., R, X., R, H., B, L., B, W., & Q, G. (2021). Mangiferin Mitigates Lipopolysaccharide-Induced Lung Injury by Inhibiting NLRP3 Inflammasome Activation. Dove Medical Press.

Cita Chicago Style (17a ed.)

N, Li, Xiong R, He R, Liu B, Wang B, y Geng Q. Mangiferin Mitigates Lipopolysaccharide-Induced Lung Injury by Inhibiting NLRP3 Inflammasome Activation. Dove Medical Press, 2021.

Cita MLA (8a ed.)

N, Li, et al. Mangiferin Mitigates Lipopolysaccharide-Induced Lung Injury by Inhibiting NLRP3 Inflammasome Activation. Dove Medical Press, 2021.